article thumbnail

Research Company Says That NY Cannabis Market To Be Worth Over $US7 Billion By 2025

Cannabis Law Report

billion by 2025, according to a new report by Grand View Research, Inc., Cannabis sales are increasing due to its medical benefits, especially in the treatment of ailments such as chronic pain, mental disorders, and cancer. This is fueling the need for effective pain management programs and treatments for such disorders.

article thumbnail

Why Consumers Prefer To Use CBD Products

Otherside Farms

In actuality, experts project that the industry will be worth sixteen billion dollars by the end of 2025. The product, although distasteful to the average Joe, might be a bar of candy for HIV/AIDS and cancer patients. Cannabidiol Alleviates Chronic Pain. Do you suffer any pain concerns? It is because.

CBD 53
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Weekly Cannabis Roundup May 7

Veriheal

a new House bill in Texas could expand the state’s restrictive medical cannabis program to include more patients and raise the state’s comically low THC limit . This measure would seriously open up the entire market and allow for more patients the legal freedom to pursue alternative therapy. . Next in news, .

Therapy 52
article thumbnail

The benefits of CBD consumption 

The Joint Blog

Indeed, only in the United States, it is projected to hit $16 billion by 2025. Arthritis-related pain is one of the most common causes of chronic pain, and CBD ointments have been shown to be a suitable option. Hemp reduces inflammation, easing joint pain and stiffness and promoting joint health.

article thumbnail

The Biological and Effective Differences of Sativa and Indica

Otherside Farms

cannabis industry is projected to reach $30 billion in market value annually by 2025. It’s why many chemotherapy patients rely on this cannabis strain to help with nausea they experience after treatments. Offers Pain Relief. In fact, due to its accessibility, the U.S. Not one cannabis strain is the same.

Indica 52
article thumbnail

Article: Who is Impacted if Marijuana is Reclassified as a Schedule II Drug

Cannabis Law Report

It is also the first FDA approved drug for the treatment of patients with Dravet syndrome. Big Pharma companies want botanical marijuana to remain illegal because it is financially beneficial to them, not because synthetic marijuana is decidedly better for patients.” billion in federal tax revenue between 2017 and 2025.

article thumbnail

New York Medical Marijuana Guide

Cannabis Law Report

Researchers predict that the market will be valued at $7 billion by the year 2025. And according to a Nielsen analytical report , the US market of legal marijuana will reach $41 billion in revenue by 2025, meaning that New York will make up close to 17% of the market share. patient application. billion in revenue.